Professional Documents
Culture Documents
1.Hemostatis凝⾎:相關⾎管壁、凝⾎因⼦、⾎⼩板
⾎管壁:內⽪細胞-選擇性通透、防⽌凝⾎的因⼦ex.PGI2、⽣成結締組織
fribinolytic:纖維蛋⽩溶解/ fribinolysis:纖維蛋⽩合成
A.⾎管壁受損:肌⾁收縮減少⾎流、內⽪細胞thrombogenic(分泌vWF、⾎⼩板活化、collagen、
plaminogen activator inhibitor 阻⽌纖維蛋⽩溶解)
Inherited Acquired
Cushing’s syndrome
Henoch-Schonlein syndrome
*⾎⼩板介紹:活10天、store(腎臟)& circulate總量⼀樣、正常值15萬到40萬、前⾝巨核細胞
(megakaryocytes)、Thrombopoietin簡稱TPO促⾎⼩板⽣成素肝臟分泌
活化⾎⼩板
修復⾎管
*Platelet glycoproteins
Ia 促進⾎⼩板與膠原蛋⽩的粘附
IIb -platelet-platelet aggregation by vWF and brinogen
-Defective in Glanzman’s thrombasthenia
Factor XIII
Fribin polymer
說明
Prothrombin(凝⾎酶原):Factor2.7.9.10+Protein S&C
Extrinsic activation factor X催化為Xa Prothrombin test (PT) - tissue factor outside
需VII參與 the blood vessels
- Clotting faster
Intrinsic activation factor X催化為Xa Activated partial - Clotting slow
需factor Xll,XI,IX thromboplastin test
(aPTT)
Common pathway Prothrombin變thrombin
需要V
HEMOSTASIS
• ⾎管壁完整性
• ⾜夠的⾎⼩板
• 正常運作的⾎⼩板
• ⾜夠⽔平的凝⾎因⼦
• 纖維蛋⽩溶解通路的正常功能
PLATELET DISORDERS
1.THROMBOCYTOPENIA⾎⼩板減少症:骨髓衰竭、脾腫⼤、紫斑、出⾎
fi
(A)Produce減少:megakaryocyte減少、化療、HIV、慢性肝炎
(B)破壞增加:特發性⾎⼩板減少性紫癜 (ITP)、輸⾎後紫癜 (HPA-1a)、⾎栓性⾎⼩板減少性
紫癜 (TTP)、溶⾎性尿毒症綜合徵 (HUS)、彌散性⾎管內凝⾎ (DIC)
2.THROMBOCYTOPATHY⾎⼩板增多症:尿毒症、遺傳性疾病、骨髓增⽣性疾病
3.TMA (Thrombotic microangiopathy)⾎栓性微⾎管病:⾎⼩板低下加上Microangiopathic
Hemolytic anemia (MAHA)。並至少要有以下其中⼀種症狀:神經學症狀、腎臟侵犯、 腸胃
道症狀。
*Renal Microvascular disease包括STEC-HUS、Atypical HUS、TTP。要先驗Shiga toxin,排除
STEC-HUS,再測ADAMTS13判斷是Atypical HUS 或TTP,如果ADAMTS13< 5 %,較像TTP
4.⾎友病:Factors VIII and IX de ciencies,治療⽤Emicizumab
5.DIC:Activation of both coagulation and brinolysis
6.Lupus phospholipid syndrome:後天⾃體免疫⾎栓、vascular thrombosis,recurrent流產,
thrombocytopenia.
7.動脈⾎栓:graywhite and friable
靜脈⾎栓:red in color
8.後天⾎栓因⼦:術後靜脈⾎栓形成、抗磷脂綜合徵
9.Deep vein thrombosis:臥床休息、⼝服避孕藥
10.PE肺栓塞:治療⽤heparin
Anticoagulant drugs
常⽤靜脈栓塞、易出⾎!!
Rivaroxiban Xa抑制物
Epti batide, tiro ban binding to the glycoprotein IIb/IIIa 常同時施予aspirin and heparin
and abciximab receptors ⽤IV
2.Anemia drugs
病 成因 副作⽤ 藥
Store as ferritin
and haemosiderin
*不確定成因不要單獨給葉酸治療
fi
ff
fi
EPO缺乏 epoetin alfa ⽪下注射糾正慢性腎功能衰竭患者
epoetin beta 的貧⾎
還⽤於治療含鉑引起的貧⾎抗癌
藥。
Cancer drugs
1.MDR:transmembrane protein (P-glycoprotein for “permeability” glycoprotein
說明
Cytotoxic antibiotics
Doxorubicin inhibits DNA and RNA synthesis, High cumulative doses are
probably by an action on cardiotoxic
topoisomerase II.
Vinca alkaloid 影響M phase
destroy spindle
Hormones and
hormone antagonists
Immunosuppressant
攻Th1 IL2 MAC Corticosteroids prednisolone inhibit cytokines IL
inhibiting transcription
factors e.g. NF‐κB and
AP‐1
Tacrolimus 同上但更有效
Mycophenolate 預防急性排斥反應
mofetil
副作⽤包括胃腸道紊亂和骨
髓抑制
fl
ff
ff
Immunosuppressant
DMARDS Methotrexate as early as possible
Rheumatoid arthritis rst‐line DMARD
(RA):循環⾃⾝抗體
associated with bone
marrow
suppression,
hepatotoxicity and
pneumonitis
-salazine 細菌在結腸中分裂產⽣
sulfapyridine
adverse e ects:rash! GI不
適、⾎液異常
Gold as sodium IM
aurothiomalate rashes, blood disorders
多被methotrexate and proteinuria
取代
*When at least two DMARDs have failed, anti‐TNF‐α agents are used.
蘇part
1.Neutrophilia中性球上升:bacterial infection, drugs, stress
2.淋巴球上升:⼩孩、viral infection
3.Infectious mononucleosis=lymphocyte上升
4.monocytosis:marrow recover,原蟲立克次體感染
5.嗜酸性球上升:過敏、parasite
6.⼩⼼:leukoerythroblastosis骨髓異常危急,hemolysis,
7.LAP score:算⽩⾎球顆粒,正常值
8.Neutropenia:WBC too low,
fi
ff
ff
9.COVID腳⾎栓、淋巴球⾎⼩板下降!嗜中性球上升!!肺栓塞、凝⾎時間增加、⾎栓多!可⽤
ddimer測(缺氧、細胞激素活化、內⽪細胞活化)重症可以預防性給抗凝⾎劑、spleen 出⾎
10.⾎液幹細胞HSC在骨髓內、周邊⾎液、臍帶⾎
骨髓幹細胞在腸股胸股
11.骨髓移植與⾎型無關需配對HLA
12.周邊幹細胞移植副作⽤:肌⾁痠痛、疲勞、發燒
13.
腸骨捐贈 周邊⾎捐贈
術後需補充⾎可⾃備 先施打G-CSF
補充鐵劑跟葉酸 解熱鎮痛劑
復原兩週 ⼀天復原
全⾝⿇醉 動脈抽取可局部⿇醉